Text Size
29 studies found for:    "Von Willebrand Disease"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: recombinant interleukin-11
2 Terminated IL-11 in Adults With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
3 Completed IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
4 Active, not recruiting Study of Biostate® in Children With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate
5 Terminated A Study With OPTIVATE® in People With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
6 Completed Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate®
7 Recruiting Extension Study of Biostate in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate
8 Completed National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
Condition: Von Willebrand Disease
Intervention:
9 Completed Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Condition: Von Willebrand Disease
Interventions: Biological: Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII);   Biological: Marketed plasma-derived VWF/FVIII concentrate
10 Withdrawn A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B
Condition: Von Willebrand Disease
Intervention: Drug: ARC1779
11 Recruiting Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Other: Patients using wilate as standard of care
12 Recruiting Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador
Conditions: Von Willebrand Disease;   Hemophilia A;   Hemophilia B
Intervention:
13 Withdrawn Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Intervention:
14 Terminated Optivate in People With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
15 Active, not recruiting Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Intervention: Biological: Recombinant von Willebrand factor (rVWF) with or without rFVIII (Advate)
16 Completed Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
Conditions: Von Willebrand Disease;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hematologic Disease
Intervention: Drug: Blood coagulation Factor VIII and vWF, human
17 Recruiting Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
Condition: Von Willebrand Disease
Intervention: Biological: Alphanate SD/HT
18 Completed The Von Willebrand Disease (VWD) International Prophylaxis Study
Condition: Von Willebrand Disease
Intervention: Drug: VWF/FVIII products (see below)
19 Completed Efficacy and Safety of IL-11 in DDAVP Unresponsive
Conditions: Hemophilia A;   Von Willebrand Disease
Intervention: Biological: Neumega (Oprelvekin, Interleukin 11, IL-11)
20 Completed Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
Condition: Von Willebrand's Disease
Intervention: Drug: von Willebrand factor
To Top

Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results
† Indicates status has not been verified in more than two years